Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,611.83
(
0.44%
)
US TECH 100
23,556.00
(
0.07%
)
Dow Jones
46,669.88
(
0.36%
)
Brent Oil
106.31
(
-0.71%
)
Bitcoin
69,055.46
(
0.29%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

immunidose

Send PM Follow Ignore
Followers 0
Posts 33
Boards Moderated 0
Alias Born 09/14/2012

immunidose

Re: freethemice post# 92330

Friday, 09/14/2012 2:04:28 PM

Friday, September 14, 2012 2:04:28 PM

Post# of 347009
Free,

1st line NSCLC Bavituximab results will carry weight on determining P111 dosage protocols. Anyone doubt that we see first-line results + BP announced simultaneously?

Well, this Ihub rookie is out of allotted post.

Thanks,
JBradley
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote